#neurological — Wednesday, July 29, 2026 (1 items)
| 0 | ℹ |
Repurposing the HMG-CoA reductase inhibitor atorvastatin for SRD5A3-congenital disorder of glycosylation.
(nature.com)
|
Communications Medicine 2026-07-29 | #glycosylation #neurological #repurposing #metabolic #genetic |